TITLE

GAO finds AMP reimbursement 36% below acquisition cost

PUB. DATE
February 2007
SOURCE
Drug Topics;2/5/2007, Vol. 151 Issue 3, p8
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article reports on the findings of the U.S. Government Accountability Office (GAO) regarding pharmacy reimbursement for generics under Medicaid. According to GAO, pharmacy reimbursement for generics under the Medicaid program would be less than their acquisition costs by an average of 36 percent under the planned change to average manufacturers price (AMP). The agency had found that the AMP of 59 out of the 77 most commonly prescribed and most expensive drugs was lower than the estimated acquisition cost.
ACCESSION #
24152730

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics